论文部分内容阅读
自1981年初,我院对25例卵巢上皮性癌Ⅰ期术后使用CH 方案化疗,以观察化疗疗程对其存活的关系,以及药物的毒性反应。资料与方法一、一般资料:1981年初至1990年10月,我科共收治根据FIGO 分期的卵巢上皮性癌Ⅰ期患者27例,其中Ⅰ_(ai)14例,Ⅰ_(aii)9例,Ⅰ_c 2例,Ⅰ_(bi)及Ⅰ_(bii)各1例。其中Ⅰ_(bii)期及Ⅰ_c 期2例又分别同时合并宫内膜腺癌及宫内膜腺棘癌Ⅰ期。27例都在本院或外院先行全子宫、双附件和/或大网膜、阑尾切除术。24例术后完全采用CH方案(CTX 和HMM),个别患者院外手术后腹腔化疗或用其它方案化疗1～3个疗程,再转
Since early 1981, 25 cases of epithelial ovarian cancer in our hospital after the use of CH regimen chemotherapy to observe the relationship between chemotherapy and its survival, as well as drug toxicity. Materials and Methods First, the general information: From early 1981 to October 1990, our department received a total of 27 patients with stage Ⅰ ovarian epithelial cancer according to FIGO staging, Ⅰ_ (ai) 14 cases, Ⅰ_ (aii) 9 cases, Ⅰ_c 2 cases, Ⅰ_ (bi) and Ⅰ_ (bii) in 1 case. In which Ⅰ_ (bii) and Ⅰ_c 2 cases were simultaneously combined with endometrial adenocarcinoma and endometrial adenocarcinoma stage Ⅰ. 27 cases were in the hospital or outside the hospital first full uterus, double attachment and / or omental, appendectomy. Twenty-four patients underwent complete CH regimen (CTX and HMM). Some patients received intraperitoneal chemotherapy after intraperitoneal or 1 to 3 courses of chemotherapy with other regimens